These include activation of the mTOR signaling pathway to promote tumor cell growth, regulation of oxidative stress responses to resist oxidative damage induced by treatment, modulation of glucose and lipid metabolism to support tumor cells’ adaptation to changing energy demands, and shaping the immune microenvironment to suppress anti-tumor immune responses (Figure 3). This evidence concerns the gene MTOR and neoplasm.